Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Study design: Real-world data, real impact Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with AUD and either type 2 diabetes or obesity who started a GLP-1 RA to similar individuals starting alternative medications
Liraglutide , marketed under the brand name Saxenda, is one such treatment approved for chronic weight management in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related condition
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Berg J.K., Shenouda S.K., Heilmann C.R., Gray A.L., Holcombe J.H
In rare cases, serious allergic reactions may occur
pharmacy benefit managers include the companys full obesity portfolio on formularies
Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen Summary of Product Characteristics (emc product 13803)
